Moberg Pharma AB (publ) (MOB) — Cash Flow Quality Index
Moberg Pharma AB (publ) (MOB) has a Cash Flow Quality Index of -0.70x as of September 2019. Operating cash flow of Skr-29.30 Million is below net income of Skr41.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Moberg Pharma AB (publ) (MOB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Moberg Pharma AB (publ) Cash Flow Quality Index (2012–2021)
Historical Cash Flow Quality Index for Moberg Pharma AB (publ) across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Moberg Pharma AB (publ) operating cash flow efficiency.
Annual Cash Flow Quality Index for Moberg Pharma AB (publ) (2012–2021)
Year-by-year earnings quality comparison for Moberg Pharma AB (publ).
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -2.04x | Skr-15.30 Million | Skr7.49 Million | ▼ -1134.5% |
| 2019 | 0.20x | Skr3.95 Million | Skr20.02 Million | ▼ -82.7% |
| 2018 | 1.14x | Skr73.89 Million | Skr64.82 Million | ▲ +8.2% |
| 2017 | 1.05x | Skr53.82 Million | Skr51.07 Million | ▲ +465.2% |
| 2016 | -0.29x | Skr-17.94 Million | Skr62.17 Million | ▼ -133.1% |
| 2015 | 0.87x | Skr30.72 Million | Skr35.18 Million | ▼ -6.9% |
| 2014 | 0.94x | Skr16.16 Million | Skr17.23 Million | ▲ +24.7% |
| 2012 | 0.75x | Skr9.48 Million | Skr12.59 Million | — |